Insight Molecular Diagnostics Inc.

IMDX · Nasdaq · SIC 2835: In Vitro & In Vivo Diagnostic Substances
271
SEC Filings

Business Summary

. Overview We are a pioneering diagnostics technology company. Our mission is to expand access to novel molecular diagnostic testing, most immediately in the transplanted organ rejection testing category. We are developing molecular diagnostic test kits designed to empower our customers to run their own tests in-house to participate in the patient-care value chain, which is counter-positioned with the send-out-testing central laboratory model. Our decentralized approach also puts testing in the ...

Next Earnings

Q2 FY2026 — expected 2026-09-09

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionIMDXdiscussed_in_filing Cybersecurity
topic_mentionIMDXdiscussed_in_filing Cybersecurity

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-262025-12-310001642380-26-000004EDGAR80K words
2025-03-242024-12-310000950170-25-043852EDGAR—
2024-04-162023-12-310001493152-24-014720EDGAR—
2023-04-122022-12-310001493152-23-012005EDGAR—
2022-03-112021-12-310001493152-22-006677EDGAR—
2021-03-192020-12-310001493152-21-006465EDGAR—
2020-03-262019-12-310001493152-20-004738EDGAR—
2019-04-012018-12-310001493152-19-004549EDGAR—
2018-04-022017-12-310001140361-18-016477EDGAR—
2017-02-272016-12-310001140361-17-009369EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-102025-09-300001193125-25-274266EDGAR46K words
2025-08-112025-06-300000950170-25-106552EDGAR—
2025-05-122025-03-310000950170-25-069213EDGAR—
2024-11-122024-09-300000950170-24-125365EDGAR—
2024-08-082024-06-300001493152-24-030793EDGAR—
2024-05-152024-03-310001493152-24-019842EDGAR—
2023-11-092023-09-300001493152-23-040121EDGAR—
2023-08-102023-06-300001493152-23-027603EDGAR—
2023-05-152023-03-310001493152-23-016796EDGAR—
2022-11-102022-09-300001493152-22-031415EDGAR—
2022-08-122022-06-300001493152-22-022151EDGAR—
2022-05-122022-03-310001493152-22-013051EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-260001493152-26-012915EDGAR8K words
2026-02-260001493152-26-008169EDGAR—
2026-02-120001493152-26-006473EDGAR—
2026-02-110001493152-26-006117EDGAR—
2025-11-100001493152-25-021513EDGAR—
2025-10-020001493152-25-016685EDGAR—
2025-09-190001493152-25-014240EDGAR—
2025-08-110001641172-25-022974EDGAR—
2025-07-020001641172-25-017590EDGAR—
2025-06-170001641172-25-015338EDGAR—

271 total filings indexed. 239 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

ACHV — ACHIEVE LIFE SCIENCES, INC. TKNO — Alpha Teknova, Inc. AWHL — Aspira Women's Health Inc. BMRA — BIOMERICA INC BZYR — BURZYNSKI RESEARCH INSTITUTE INC CDIO — Cardio Diagnostics Holdings, Inc. CLDX — Celldex Therapeutics, Inc. IDXX — IDEXX LABORATORIES INC /DE

Company Identity

CIK0001642380
TickerIMDX
ExchangeNasdaq
SIC2835: In Vitro & In Vivo Diagnostic Substances
IncorporatedCA

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 03b4f2de7d35ed1385b99e01fbe12b5f63e7ad5675053827c2611a7c0ae603e4
parent: 41b5d0e5df0cb8afb6f1843fe2f841246ee0cdf3e676e360f02c3c2a51b5ea08
content hash: 7aadf377672e7a5b371fc4b39668f8a12d41ffdfb0515339edca286b07788b4e
signed: 2026-04-13T04:45:40.366Z
sources: 22 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf